Myriad Genetics Presents at BofA and Goldman Sachs Healthcare Conferences
Myriad Genetics (NASDAQ: MYGN), a molecular diagnostic testing and precision medicine company,...
Myriad Genetics (NASDAQ: MYGN), a molecular diagnostic testing and precision medicine company,...